Comparison of carbapenem-susceptible and carbapenem-resistant <i>Enterobacterales</i> at nine sites in the USA, 2013-2016: a resource for antimicrobial resistance investigators.

Publication Year: 2023

DOI:
10.1099/mgen.0.001119

PMCID:
PMC10711308

PMID:
37987646

Journal Information

Full Title: Microb Genom

Abbreviation: Microb Genom

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Microbiology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"pmc pmc10711308 pmc10711308 10711308 37987646 37987646 001119 10 1099/mgen 0 001119 bioresources pathogens and epidemiology comparison of carbapenem-susceptible and carbapenem-resistant enterobacterales at nine sites in the usa 2013-2016: a resource for antimicrobial resistance investigators http://mgen microbiologyresearch org disclaimer: the findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the centers for disease control and prevention *correspondence: joseph d lutgring yix4@cdc gov;jlutgring@cdc gov sequence reads were submitted to ncbi's sequence read archive (sra) database under the bioproject prjna288601 2023 21 11 2023 21 11 2023 [ comment ] 9 11 001119 07 7 2023 08 10 2023 (c) 2023 the authors2023 https://creativecommons org/licenses/by/4 0/ this is an open-access article distributed under the terms of the creative commons attribution license.; sequence reads were submitted to ncbi's sequence read archive (sra) database under the bioproject prjna288601.; sequence reads were submitted to ncbi's sequence read archive (sra) database under the bioproject prjna288601 (file s1)."

Code Sharing
Evidence found in paper:

"Conflicts of interest The authors declare that there are no conflicts of interest."

Evidence found in paper:

"Funding information J.R.B., D.E.J., A.P., R.B. and D.M.E. were funded in part by a contract from the Centers for Disease Control and Prevention (CDC AMD #200-2016-92313). J.K.J. was funded in part by the following contracts from the Centers for Disease Control and Prevention (Sentinel Site Surveillance for AR Organisms; Contract #200-2011-42064 and Sentinel Site Surveillance for AR Organisms II; Contract #200-2011-42064/0004)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025